1. Home
  2. VKTX vs ALRM Comparison

VKTX vs ALRM Comparison

Compare VKTX & ALRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VKTX
  • ALRM
  • Stock Information
  • Founded
  • VKTX 2012
  • ALRM 2000
  • Country
  • VKTX United States
  • ALRM United States
  • Employees
  • VKTX N/A
  • ALRM N/A
  • Industry
  • VKTX Biotechnology: Pharmaceutical Preparations
  • ALRM Computer Software: Prepackaged Software
  • Sector
  • VKTX Health Care
  • ALRM Technology
  • Exchange
  • VKTX Nasdaq
  • ALRM Nasdaq
  • Market Cap
  • VKTX 3.0B
  • ALRM 2.8B
  • IPO Year
  • VKTX 2015
  • ALRM 2015
  • Fundamental
  • Price
  • VKTX $33.26
  • ALRM $51.65
  • Analyst Decision
  • VKTX Strong Buy
  • ALRM Buy
  • Analyst Count
  • VKTX 12
  • ALRM 6
  • Target Price
  • VKTX $86.42
  • ALRM $64.33
  • AVG Volume (30 Days)
  • VKTX 5.3M
  • ALRM 482.5K
  • Earning Date
  • VKTX 10-22-2025
  • ALRM 11-06-2025
  • Dividend Yield
  • VKTX N/A
  • ALRM N/A
  • EPS Growth
  • VKTX N/A
  • ALRM 17.96
  • EPS
  • VKTX N/A
  • ALRM 2.37
  • Revenue
  • VKTX N/A
  • ALRM $975,867,000.00
  • Revenue This Year
  • VKTX N/A
  • ALRM $7.89
  • Revenue Next Year
  • VKTX N/A
  • ALRM $4.24
  • P/E Ratio
  • VKTX N/A
  • ALRM $21.69
  • Revenue Growth
  • VKTX N/A
  • ALRM 7.81
  • 52 Week Low
  • VKTX $18.92
  • ALRM $48.23
  • 52 Week High
  • VKTX $81.73
  • ALRM $70.06
  • Technical
  • Relative Strength Index (RSI)
  • VKTX 62.67
  • ALRM 36.92
  • Support Level
  • VKTX $25.04
  • ALRM $51.07
  • Resistance Level
  • VKTX $32.85
  • ALRM $53.14
  • Average True Range (ATR)
  • VKTX 1.49
  • ALRM 1.21
  • MACD
  • VKTX 1.01
  • ALRM -0.16
  • Stochastic Oscillator
  • VKTX 88.54
  • ALRM 13.83

About VKTX Viking Therapeutics Inc.

Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.

About ALRM Alarm.com Holdings Inc.

Alarm.com Holdings Inc has a cloud-based platform that offers an expansive suite of IoT solutions addressing world-wide opportunities in the residential, multi-family, small business and enterprise commercial markets. It has two reportable segments: Alarm.com & Other. The Alarm.com segment represents the cloud-based Software platforms for intelligently connected property & related solutions. The other segment is focused on researching, developing & offering residential & commercial automation solutions & energy management products & services in adjacent markets. The majority of revenue is from the Alarm.com segment. The platform allows home & business owners to secure their properties and automate & control an array of connected devices.

Share on Social Networks: